What is Power?
Power is a patient-centric platform designed to bridge the gap between patients seeking access to life-changing clinical trials and researchers struggling with patient recruitment. Recognizing that convoluted processes and complex medical jargon often exclude patients from cutting-edge treatments, Power aims to simplify the discovery and evaluation of novel therapies. The company addresses the critical issue of clinical trial delays, where approximately 86% are attributed to insufficient patient enrollment. By making clinical trial participation more accessible and understandable, Power seeks to offer hope to patients and accelerate the approval of breakthrough drugs.
How much funding has Power raised?
Power has raised a total of $19M across 2 funding rounds:
Angel/Seed
$7M
Series A
$12M
Angel/Seed (2022): $7M with participation from Footwork, Charles River Ventures, South Park Commons, AirAngels, and ARTIS Ventures
Series A (2024): $12M led by Contrary Capital and Kin Ventures
Key Investors in Power
Contrary Capital
Contrary Capital is a venture fund that supports early-career talent, investing in companies founded or joined by emerging engineers, designers, and product minds. They provide a career-long support community for their portfolio companies.
Charles River Ventures
Charles River Ventures (CRV) is a venture capital firm specializing in early-stage tech startups. With a history dating back to 1970, CRV has a proven track record of investing in successful companies and acts as a committed, long-term partner to founders.
ARTIS Ventures
ARTIS Ventures is a venture capital fund focused on Tech Bio+Health, investing in data-driven life sciences companies that aim to improve human health. They champion an engineering-first approach to develop personalized therapeutics and efficient drug discovery.
What's next for Power?
The recent major strategic investment signifies a crucial phase for Power, likely enabling the company to scale its operations, enhance its platform's technological capabilities, and expand its market reach. This infusion of capital is expected to fuel further development in patient outreach and researcher collaboration tools. As Power continues to grow, its focus will likely remain on streamlining the clinical trial process, potentially exploring new therapeutic areas and forging deeper partnerships within the healthcare and pharmaceutical industries. The company's trajectory suggests a strong commitment to innovation and patient advocacy in the pursuit of faster drug development and improved patient outcomes.
See full Power company page
